BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Receives $16.71 Average Target Price from Analysts
Shares of BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) have been given an average recommendation of “Hold” by the seven brokerages that are presently covering the firm, MarketBeat Ratings reports. Four analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month […]
More Stories
Kentucky First Federal Bancorp (NASDAQ:KFFB) Short Interest Update
Kentucky First Federal Bancorp (NASDAQ:KFFB – Get Free Report) saw a significant decline in short interest in the month of...
Mitsubishi Motors Co. (OTCMKTS:MMTOF) Short Interest Down 17.6% in September
Mitsubishi Motors Co. (OTCMKTS:MMTOF – Get Free Report) was the target of a significant decline in short interest during the...
Short Interest in AltaGas Ltd. (OTCMKTS:ATGFF) Rises By 23.2%
AltaGas Ltd. (OTCMKTS:ATGFF – Get Free Report) was the recipient of a large increase in short interest during the month...
Ald S.A. (OTCMKTS:ALLDF) Short Interest Up 23.3% in September
Ald S.A. (OTCMKTS:ALLDF – Get Free Report) was the recipient of a significant growth in short interest during the month...
The Old Guard 2 Release Date, Returning Cast, and New Additions
Fans have been waiting patiently for the sequel to 2020’s The Old Guard, which was a smash hit for streaming...
Premier, Inc. (NASDAQ:PINC) Given Average Recommendation of “Hold” by Brokerages
Premier, Inc. (NASDAQ:PINC – Get Free Report) has earned a consensus recommendation of “Hold” from the nine research firms that...